Федон Линдберг - X-фактор здорового веса. Как добиться естественной стройности, позаботившись о кишечнике

82. Weigle DS, Breen PA, Matthys CC, Callahan HS, Meeuws KE, Burden VR, Purnell JQ. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005 Jul;82(1):41–8

83. Sofi, F. et al. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomized dietary intervention trial. British Journal of Nutrition / Volume 111 / Issue 11 / June 2014

84. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014 Oct 15;180(8):763–75

85. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014 Feb 11;129(6):643–59

86. Hansen, John-Bjarne; Enga, Kristin Fjeldstad. Coffee consumption and risk of venous thromboembolism. I: Coffee in health and disease prevention. Academic Press 2015 ISBN 9780124095175. s. 403–407 UiT

87. Siasos G, Oikonomou E, Chrysohoou C, Tousoulis D, Panagiotakos D, Zaromitidou M, Zisimos K, Kokkou E, Marinos G, Papavassiliou AG, Pitsavos C, Stefanadis C. Con sumption of a boiled Greek type of coffee is associated with improved endothelial function: the Ikaria study. Vasc Med. 2013 Apr;18(2):55–62

88. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014 Feb;37(2):569–86. Review

89. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 2014 Feb;53(1):25–38. Review

90. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14;169(22):2053-63. doi: 10.1001/archinternmed.2009.439. Review.

91. Coffee consumption and blood homocysteine, Institute for scientific information on coffee: http://coffeeandhealth.org/topic-overview/coffee-consumption-and-blood-homocysteine/

92. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701–12. Review

93. Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P, Leonard B. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med. 2012 Jun 29;10:66

94. Logan AC, Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005;64(3):533–8

95. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009 Mar 19;1(1):6

96. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel JM. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755–64

97. Sherwin E, Rea K, Dinan TG, Cryan JF. A gut (microbiome) feeling about the brain. Curr Opin Gastroenterol. 2016 Mar;32(2):96–102

98. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015 Oct 14;9:392

99. Dinan TG, Cryan JF. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):552–8

100. Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015 Apr;63:1–9

101. Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C. Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol. 2014;817:221–39

102. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013 Nov 15;74(10):720–6

103. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot C, Pichelin M, Cazaubiel M, Cazaubiel JM. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755–64

104. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013 Jun;144(7):1394–401, 1401. e1–4

105. Keisersnitt – faktaark med statistikk. Folkehelseinstituttet. https://www.fhi.no/fp/svangerskap/gravide-og-fodende-kvinners-helse/keisersnitt-faktaark-med-statisti/Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008 Mar;87(3):534–8

106. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A.The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012 Sep;96(3): 544–51

107. Collado MC, Laitinen K, Salminen S, Isolauri E. Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr Res. 2012 Jul;72(1):77–85

108. «Vi lever lenger enn før». Folkehelseinstituttet. https://www.fhi.no/nettpub/hin/befolkning-og-levealder/levealderen-i-norge-folkehelserap/#vi-lever-lenger-enn-foer

109. Siamak Yazdankhah, Jørgen Lassen, Tore Midtvedt, Claus Ola Solberg. «Historien om antibiotika». http://tidsskriftet.no/article/3112767

110. Strachan, D. P. (1989). Hay fever, hygiene, and household size. BMJ 299 (6710): 1259–60.

111. Strachan, D. (2000). Family size, infection and atopy: The first decade of the ’hygiene hypothesis’. Thorax 55 (90001): 2S

112. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001;357:607

113. Raison CL, Lowry CA, Rook GAW. Inflammation, sanitation and consternation: loss of contact with co-evolved, tolerogenic micro-organisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry 2010;67(12) 1211–24

114. Rook GAW, Lowry CA, Raison CL. Microbial Old Friends, immunoregulation and stress resilience. Evolution, Medicine and Public Health. 2013: 46–64

115. Rook, G. A. W.; Lowry, C. A.; Raison, C. L. (2013). Microbial ’Old Friends’, immunoregulation and stress resilience. Evolution, Medicine, and Public Health 2013: 46–64

116. Rook GA, Dalgleish A (2011). «Infection, immunoregulation and cancer”. Immunological Reviews 240: 141–59

117. Giovanni Musso, Roberto Gambino, Maurizio Cassader. Obesity, Diabetes, and Gut Microbiota: The hygiene hypothesis expanded? Diabetes Care. 2010 October; 33(10): 2277–2284

118. Shengli Ding, Pauline K. Lund. Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care. 2011 July; 14(4): 328–333

119. Ningwen Tai, F. Susan Wong, Li Wen. The role of gut microbiota in the development of type 1, obesity and type 2 diabetes mellitus. Rev Endocr Metab Disord. 2015 March; 16(1): 55–65